Literature DB >> 27183596

Andrographolide Restores Steroid Sensitivity To Block Lipopolysaccharide/IFN-γ-Induced IL-27 and Airway Hyperresponsiveness in Mice.

Wupeng Liao1, W S Daniel Tan1, W S Fred Wong2.   

Abstract

LPS and IFN-γ alone or in combination have been implicated in the development of steroid resistance. Combined LPS/IFN-γ strongly upregulates IL-27 production, which has been linked to steroid-resistant airway hyperresponsiveness (AHR). Andrographolide, a bioactive molecule isolated from the plant Andrographis paniculata, has demonstrated anti-inflammatory and antioxidant properties. The present study investigated whether andrographolide could restore steroid sensitivity to block LPS/IFN-γ-induced IL-27 production and AHR via its antioxidative property. The mouse macrophage cell line Raw 264.7, mouse primary lung monocytes/macrophages, and BALB/c mice were treated with LPS/IFN-γ, in the presence and absence of dexamethasone and/or andrographolide. Levels of IL-27 in vitro and in vivo were examined and mouse AHR was assessed. Dexamethasone alone failed to inhibit LPS/IFN-γ-induced IL-27 production and AHR in mice. Andrographolide significantly restored the suppressive effect of dexamethasone on LPS/IFN-γ-induced IL-27 mRNA and protein levels in the macrophage cell line and primary lung monocytes/macrophages, mouse bronchoalveolar lavage fluid and lung tissues, and AHR in mice. LPS/IFN-γ markedly reduced the nuclear level of histone deacetylase (HDAC)2, an essential epigenetic enzyme that mediates steroid anti-inflammatory action. LPS/IFN-γ also decreased total HDAC activity but increased the total histone acetyltransferase/HDAC activity ratio in mouse lungs. Andrographolide significantly restored nuclear HDAC2 protein levels and total HDAC activity, and it diminished the total histone acetyltransferase/HDAC activity ratio in mouse lungs exposed to LPS/IFN-γ, possibly via suppression of PI3K/Akt/HDAC2 phosphorylation, and upregulation of the antioxidant transcription factor NF erythroid-2-related factor 2 level and DNA binding activity. Our data suggest that andrographolide may have therapeutic value in resensitizing steroid action in respiratory disorders such as asthma.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27183596     DOI: 10.4049/jimmunol.1502114

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  CpG oligodeoxynucleotides attenuate RORγt-mediated Th17 response by restoring histone deacetylase-2 in cigarette smoke-exposure asthma.

Authors:  Hongtao Li; Qimei Ye; Yusen Lin; Xuena Yang; Xiaoling Zou; Hailing Yang; Wenbin Wu; Ping Meng; Tiantuo Zhang
Journal:  Cell Biosci       Date:  2021-05-20       Impact factor: 7.133

2.  Restoration of HDAC2 and Nrf2 by andrographolide overcomes corticosteroid resistance in chronic obstructive pulmonary disease.

Authors:  Wupeng Liao; Albert Y H Lim; W S Daniel Tan; John Abisheganaden; W S Fred Wong
Journal:  Br J Pharmacol       Date:  2020-06-01       Impact factor: 8.739

Review 3.  Advances in adjunct therapy against tuberculosis: Deciphering the emerging role of phytochemicals.

Authors:  Samreen Fatima; Anjna Kumari; Ved Prakash Dwivedi
Journal:  MedComm (2020)       Date:  2021-08-05

4.  DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis.

Authors:  Yuanyuan Wang; Bin Wei; Danping Wang; Jingjing Wu; Jianhua Gao; Haiqing Zhong; Yang Sun; Qiang Xu; Wen Liu; Yanhong Gu; Wenjie Guo
Journal:  Acta Pharm Sin B       Date:  2021-04-29       Impact factor: 11.413

5.  Coadministration of Stigmasterol and Dexamethasone (STIG+DEX) Modulates Steroid-Resistant Asthma.

Authors:  Abigail Hohoayi; Aaron O Antwi; Veronica Amoah; Newman Osafo; Paul P O Sampene; George Ainooson
Journal:  Mediators Inflamm       Date:  2022-08-24       Impact factor: 4.529

Review 6.  Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective.

Authors:  Parteek Prasher; Mousmee Sharma; Meenu Mehta; Keshav R Paudel; Saurabh Satija; Dinesh K Chellappan; Harish Dureja; Gaurav Gupta; Murtaza M Tambuwala; Poonam Negi; Peter R Wich; Nicole G Hansbro; Philip M Hansbro; Kamal Dua
Journal:  Chem Biol Interact       Date:  2020-05-04       Impact factor: 5.192

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.